Human platelet lysate stimulates high-passage and senescent human multipotent mesenchymal stromal cell growth and rejuvenation in vitro

Cytotherapy

Volumn 15, Issue 12, 2013, Pages 1469-1483

  Griffiths, Sarah ^a   Baraniak, Priya R ^a   Copland, Ian B ^a,b   Nerem, Robert M ^a,c   McDevitt, Todd C ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Animal serum free culture; Human platelet lysate; Multipotent mesenchymal stromal cells; Proliferation; Rejuvenation; Senescence

Indexed keywords

BETA GALACTOSIDASE;

ARTICLE; CELL CULTURE; CELL EXPANSION; CELL GROWTH; CELL PROLIFERATION; CELL SIZE; CELLULAR PARAMETERS; CONTROLLED STUDY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; MESENCHYMAL STROMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REJUVENATION; SENESCENCE; THROMBOCYTE FUNCTION;

ANIMALIA; BOVINAE;

ANIMAL SERUM-FREE CULTURE; HUMAN PLATELET LYSATE; MULTIPOTENT MESENCHYMAL STROMAL CELLS; PROLIFERATION; REJUVENATION; SENESCENCE;

ANIMALS; CATTLE; CELL AGING; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CULTURE MEDIA; FLOW CYTOMETRY; HUMANS; MESENCHYMAL STROMAL CELLS; PLATELET-RICH PLASMA; SERUM;

EID: 84887121126     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2013.05.020     Document Type: Article

References (54)

1. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
2. Erices A., Conget P., Minguell J.J. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 2000, 109:235-242.
3. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001, 7:211-228.
4. Pittenger M.F. Mesenchymal stem cells from adult bone marrow. Methods Mol Biol 2008, 449:27-44.
5. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
6. Baraniak P.R., McDevitt T.C. Stem cell paracrine actions and tissue regeneration. Regen Med 2010, 5:121-143.
7. Newman R.E., Yoo D., LeRoux M.A., Danilkovitch-Miagkova A. Treatment of inflammatory diseases with mesenchymal stem cells. Inflamm Allergy Drug Targets 2009, 8:110-123.
8. Barry F.P., Murphy J.M. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 2004, 36:568-584.
9. Lalu M.M., McIntyre L., Pugliese C., Fergusson D., Winston B.W., Marshall J.C., et al. Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One 2012, 7:e47559.
10. Bernardo M.E., Fibbe W.E. Safety and efficacy of mesenchymal stromal cell therapy in autoimmune disorders. Ann N Y Acad Sci 2012, 1266:107-117.
11. Boregowda S.V., Phinney D.G. Therapeutic applications of mesenchymal stem cells: current outlook. BioDrugs 2012, 26:201-208.
12. Bieback K., Kinzebach S., Karagianni M. Translating research into clinical scale manufacturing of mesenchymal stromal cells. Stem Cells Int 2010, 2010:193519. http://dx.doi.org/10.4061/2010/193519.
13. Spees J.L., Gregory C.A., Singh H., Tucker H.A., Peister A., Lynch P.J., et al. Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther 2004, 9:747-756.
14. Mackensen A., Dräger R., Schlesier M., Mertelsmann R., Lindemann A. Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells. Cancer Immunol Immun 2000, 49:152-156.
15. Selvaggi T.A., Walker R.E., Fleisher T.A. Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood 1997, 89:776-779.
16. Warnke P.H., Humpe A., Strunk D., Stephens S., Warnke F., Wiltfang J., et al. Aclinically-feasible protocol for using human platelet lysate and mesenchymal stem cells in regenerative therapies. JCraniomaxillofac Surg 2013, 41:153-161.
17. Li X.Y., Ding J., Zheng Z.H., Li X.Y., Wu Z.B., Zhu P. Long-term culture in vitro impairs the immunosuppressive activity of mesenchymal stem cells on T cells. Mol Med Rep 2012, 6:1183-1189.
18. Crisostomo P.R., Wang M., Wairiuko G.M., Morrell E.D., Terrell A.M., Seshadri P., et al. High passage number of stem cells adversely affects stem cell activation and myocardial protection. Shock 2006, 26:575-580.
19. Wagner W., Horn P., Castoldi M., Diehlmann A., Bork S., Saffrich R., et al. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One 2008, 3:e2213.
20. Bieback K., Hecker A., Kocaomer A., Lannert H., Schallmoser K., Strunk D., et al. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 2009, 27:2331-2341.
21. Kocaoemer A., Kern S., Kluter H., Bieback K. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 2007, 25:1270-1278.
22. Schallmoser K., Bartmann C., Rohde E., Reinisch A., Kashofer K., Stadelmeyer E., et al. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 2007, 47:1436-1446.
23. Perez-Ilzarbe M., Diez-Campelo M., Aranda P., Tabera S., Lopez T., del Canizo C., et al. Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy. Transfusion 2009, 49:1901-1910.
24. Ben Azouna N., Jenhani F., Regaya Z., Berraeis L., Ben Othman T., Ducrocq E., et al. Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum. Stem Cell Res Ther 2012, 3:6.
25. Xia W., Li H., Wang Z., Xu R., Fu Y., Zhang X., et al. Human platelet lysate supports ex vivo expansion and enhances osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. Cell Biol Int 2011, 35:639-643.
26. Bartosh T.J., Ylöstalo J.H., Mohammadipoor A., Bazhanov N., Coble K., Claypool K., et al. Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc Natl Acad Sci U S A 2010, 107:13724-13729.
27. Hayflick L. Subculturing human diploid fibroblast cultures. Tissue Culture Methods and Applications 1973, 220-223. Academic Press, New York. P.F. Kruse, M.K. Patterson (Eds.).
28. Miyazawa K., Hondo T., Kanaya T., Tanaka S., Takakura I., Itani W., et al. Characterization of newly established bovine intestinal epithelial cell line. Histochem Cell Biol 2010, 133:125-134.
29. Horn P., Bokermann G., Cholewa D., Bork S., Walenda T., Koch C., et al. Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells. Cytotherapy 2010, 12:888-898.
30. Fekete N., Gadelorge M., Fürst D., Maurer C., Dausend J., Fleury-Cappellesso S., et al. Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components. Cytotherapy 2012, 14:540-554.
31. Horwitz E.M., Gordon P.L., Koo W.K.K., Marx J.C., Neel M.D., McNall R.Y., et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci U S A 2002, 99:8932-8937.
32. Govindasamy V., Ronald V.S., Abdullah A.N.B., Ganesan Nathan K.R., Aziz Z.A.C.A., Abdullah M., et al. Human platelet lysate permits scale-up of dental pulp stromal cells for clinical applications. Cytotherapy 2011, 13:1221-1233.
33. Doucet C., Ernou I., Zhang Y., Llense J.-R., Begot L., Holy X., et al. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. JCell Physiol 2005, 205:228-236.
34. Copland I., Galipeau J. Death and inflammation following somatic cell transplantation. Semin Immunopathol 2011, 33:535-550.
35. European Agency for the Evaluation of Medicinal Products, Committee for Proprietary Medicinal Products (CPMP) Note for guidance on use of bovine serum in the manufacture of human biological medicinal product 2003, EMA, London, (CPMP/BWP/1793/02). Available from, [cited 2012 Nov 18]. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003675.pdf.
36. Bieback K., Ha V.A., Hecker A., Grassl M., Kinzebach S., Solz H., et al. Altered gene expression in human adipose stem cells cultured with fetal bovine serum compared to human supplements. Tissue Eng Part A 2010, 16:3467-3484.
37. Ponte A.L., Marais E., Gallay N., Langonné A., Delorme B., Hérault O., et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007, 25:1737-1745.
38. Dallari D., Fini M., Stagni C., Torricelli P., Nicoli Aldini N., Giavaresi G., et al. In vivo study on the healing of bone defects treated with bone marrow stromal cells, platelet-rich plasma, and freeze-dried bone allografts, alone and in combination. JOrthop Res 2006, 24:877-888.
39. Abdelrazik H., Spaggiari G.M., Chiossone L., Moretta L. Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function. Eur J Immunol 2011, 41:3281-3290.
40. Rodrigues M., Griffith L.G., Wells A. Growth factor regulation of proliferation and survival of multipotential stromal cells. Stem Cell Res Ther 2010, 1:32.
41. Fekete N., Rojewski M.T., Fürst D., Kreja L., Ignatius A., Dausend J., et al. GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC. PLoS One 2012, 7:e43255.
42. Salem H.K., Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 2010, 28:585-596.
43. Lee R.H., Hsu S.C., Munoz J., Jung J.S., Lee N.R., Pochampally R., et al. Asubset of human rapidly self-renewing marrow stromal cells preferentially engraft in mice. Blood 2006, 107:2153-2161.
44. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., et al. Abiomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 1995, 92:9363-9367.
45. Bonab M., Alimoghaddam K., Talebian F., Ghaffari S., Ghavamzadeh A., Nikbin B. Aging of mesenchymal stem cell in vitro. BMC Cell Biol 2006, 7:14.
46. Colter D.C., Sekiya I., Prockop D.J. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci U S A 2001, 98:7841-7845.
47. Majore I., Moretti P., Hass R., Kasper C. Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cord. Cell Commun Signal 2009, 7:6.
48. Kern S., Eichler H., Stoeve J., Klüter H., Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006, 24:1294-1301.
49. Simonsen J.L., Rosada C., Serakinci N., Justesen J., Stenderup K., Rattan S.I., et al. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 2002, 20:592-596.
50. Forte G., Minieri M., Cossa P., Antenucci D., Sala M., Gnocchi V., et al. Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation. Stem Cells 2006, 24:23-33.
51. Tamama K., Kawasaki H., Wells A. Epidermal growth factor (EGF) treatment on multipotential stromal cells (MSCs): possible enhancement of therapeutic potential of MSC. JBiomed Biotechnol 2010, 2010:795385. http://dx.doi.org/10.1155/2010/795385.
52. Stolzing A., Jones E., McGonagle D., Scutt A. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 2008, 129:163-173.
53. Stolzing A., Coleman N., Scutt A. Glucose-induced replicative senescence in mesenchymal stem cells. Rejuvenation Res 2006, 9:31-35.
54. Wagner W., Bork S., Horn P., Krunic D., Walenda T., Diehlmann A., et al. Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS One 2009, 4:e5846.